T. Rowe Price Investment Management’s National Healthcare NHC Stock Holding History

T. Rowe Price Investment Management’s Portfolio NHC Stock Details NHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$22.7M	Buy	+107,248	New	+$19.7M	0.01%	531

Other funds holding NHC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

MSIIA

Morgan Stanley Institutional Investment Advisors Greenwood Village, Colorado $1.07B AUM 29.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

T. Rowe Price Investment Management's NHC Position: Q2 2026 in Review

T. Rowe Price Investment Management opened a new position in National Healthcare (NHC) in Q2 2026: 107,248 shares worth $22.7M. The stake represents 0.01% of the portfolio and ranks #531 among its holdings.

249 funds tracked by Wall St. Rank hold NHC as of Q2 2026.

T. Rowe Price Investment Management held 107,248 shares of National Healthcare worth $22.7M as of Q2 2026.
National Healthcare was a new T. Rowe Price Investment Management position in Q2 2026.
National Healthcare made up 0.01% of T. Rowe Price Investment Management's portfolio in Q2 2026, its #531 holding.
249 funds tracked by Wall St. Rank held National Healthcare as of Q2 2026.

Based on T. Rowe Price Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.